Aproval for the migration of the advia centaur anti-hbs2 (ahbs2) assay to the atellica im analyzer.
| Device | Atellica IM Anti-Hepatitis B surface Antigen 2 (aHBs2), Atellica IM Anti-Hepatitis B surface Antigen 2 Quality Control ( |
| Classification Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
| Generic Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
| Applicant | SIEMENS HEALTHCARE DIAGNOSTICS INC. |
| Date Received | 2017-07-14 |
| Decision Date | 2018-05-23 |
| PMA | P100039 |
| Supplement | S005 |
| Product Code | LOM |
| Docket Number | Premarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration Follow FDA En Español Search FDA Home Food Drugs Medical Devices Radia |
| Advisory Committee | Microbiology |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | SIEMENS HEALTHCARE DIAGNOSTICS INC. 511 Benedict Ave. tarrytown, NY 10591 |
Supplemental Filings
| Supplement Number | Date | Supplement Type |
|---|
| P100039 | | Original Filing |
| S015 |
2022-03-22 |
30-day Notice |
| S014 |
2022-01-20 |
30-day Notice |
| S013 |
2021-04-01 |
30-day Notice |
| S012 |
2021-03-26 |
30-day Notice |
| S011 |
2020-12-22 |
Real-time Process |
| S010 |
2020-07-31 |
30-day Notice |
| S009 |
2020-03-09 |
30-day Notice |
| S008 |
2020-02-21 |
30-day Notice |
| S007 |
2019-02-01 |
30-day Notice |
| S006 |
2018-07-19 |
Real-time Process |
| S005 |
2017-07-14 |
Normal 180 Day Track |
| S004 |
2015-07-13 |
Normal 180 Day Track |
| S003 |
2015-06-11 |
30-day Notice |
| S002 |
2012-09-28 |
Real-time Process |
| S001 |
2012-04-30 |
Normal 180 Day Track |
NIH GUDID Devices